Name | Benzyl [(2S)-6-(acryloylamino)-1-{4-[(7-hydroxy-2-oxo-2H-chromen-3-yl)carbonyl]-1-piperazinyl}-1-oxo-2-hexanyl]carbamate |
---|---|
Synonyms |
Carbamic acid, N-[(1S)-1-[[4-[(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)carbonyl]-1-piperazinyl]carbonyl]-5-[(1-oxo-2-propen-1-yl)amino]pentyl]-, phenylmethyl ester
Benzyl [(2S)-6-(acryloylamino)-1-{4-[(7-hydroxy-2-oxo-2H-chromen-3-yl)carbonyl]-1-piperazinyl}-1-oxo-2-hexanyl]carbamate VA5 |
Description | VA5 is a BTK kinaseinhibitor. VA5 has the potential to be used to study diseases associated with BTK kinase activity. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 955.8±65.0 °C at 760 mmHg |
Molecular Formula | C31H34N4O8 |
Molecular Weight | 590.624 |
Flash Point | 531.8±34.3 °C |
Exact Mass | 590.237671 |
LogP | 1.80 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.610 |